Dr Shohta Ueno is a Executive Director Assistant General Counsel, Head of International IP Litigation at Regeneron Pharmaceuticals Inc., a leading biopharmaceutical company where he advises the company on a broad range of complex, multi-jurisdictional disputes. While Shohta deals with all matters relating to disputes, he focuses mostly on non-US IP matters and helps the company navigate through increasingly complex IP landscape.
Shohta joined Regeneron in 2018 from a leading IP litigation practice based in the UK. Shohta is also a trained scientist – he obtained a PhD in Virology as well as an undergraduate degree in Natural Sciences from the University of Cambridge.
Year Joined Firm: 2018
Education/Alumni: University of Cambridge
Network Memberships:
- AIPPI (Pharma Committee)
- CIPA (Life Sciences committee)
- IP Fed (Council Member)
- Included in Global In-House Elite 2026 by WIPR
- Awarded In-house Intellectual Property Individual of the Year by Lexology European Awards 2026
- Rising Star Awards Life Sciences EMEA in 2021 from Managing IP